|
Name |
Phthalic acid, methyl 2-pentyl ester
|
Molecular Formula | C14H18O4 | |
IUPAC Name* |
1-O-methyl 2-O-pentan-2-yl benzene-1,2-dicarboxylate
|
|
SMILES |
CCCC(C)OC(=O)C1=CC=CC=C1C(=O)OC
|
|
InChI |
InChI=1S/C14H18O4/c1-4-7-10(2)18-14(16)12-9-6-5-8-11(12)13(15)17-3/h5-6,8-10H,4,7H2,1-3H3
|
|
InChIKey |
YTHPHGWTOWIKBU-UHFFFAOYSA-N
|
|
Synonyms |
Phthalic acid, methyl 2-pentyl ester
|
|
CAS | NA | |
PubChem CID | 6424485 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 250.29 | ALogp: | 2.9 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 52.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 18 | QED Weighted: | 0.749 |
Caco-2 Permeability: | -4.438 | MDCK Permeability: | 0.00003330 |
Pgp-inhibitor: | 0.294 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.084 |
30% Bioavailability (F30%): | 0.973 |
Blood-Brain-Barrier Penetration (BBB): | 0.16 | Plasma Protein Binding (PPB): | 89.10% |
Volume Distribution (VD): | 1.203 | Fu: | 3.60% |
CYP1A2-inhibitor: | 0.894 | CYP1A2-substrate: | 0.752 |
CYP2C19-inhibitor: | 0.886 | CYP2C19-substrate: | 0.206 |
CYP2C9-inhibitor: | 0.757 | CYP2C9-substrate: | 0.864 |
CYP2D6-inhibitor: | 0.134 | CYP2D6-substrate: | 0.184 |
CYP3A4-inhibitor: | 0.297 | CYP3A4-substrate: | 0.161 |
Clearance (CL): | 11.705 | Half-life (T1/2): | 0.536 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.808 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.003 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.35 | Carcinogencity: | 0.031 |
Eye Corrosion: | 0.024 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.037 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000299 | 0.642 | D0GY5Z | 0.355 | ||||
ENC001027 | 0.635 | D06LYG | 0.348 | ||||
ENC001356 | 0.611 | D0S5CU | 0.333 | ||||
ENC003076 | 0.586 | D08JIV | 0.326 | ||||
ENC001802 | 0.554 | D0I2WV | 0.326 | ||||
ENC000586 | 0.552 | D0B7OD | 0.324 | ||||
ENC000154 | 0.550 | D05OFX | 0.320 | ||||
ENC001800 | 0.527 | D04OSE | 0.318 | ||||
ENC000300 | 0.523 | D0G2MH | 0.313 | ||||
ENC004744 | 0.515 | D0Y0JH | 0.308 |